Related Experiment Videos
Genetics of arterial prothrombotic risk states
1Johns Hopkins University, Baltimore, Maryland 21205, USA.
Insights
Genetic factors influence arterial thrombosis, a key element in coronary artery disease. Understanding these inherited markers can improve patient management and personalize treatments for vascular disease.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Thrombosis Research
Background:
- Coronary artery disease (CAD) is a major global cause of mortality.
- Myocardial infarction (MI) involves complex pathophysiology, including atherosclerosis and thrombosis.
- Genetic predisposition plays a significant role in the development of arterial thrombosis.
Purpose of the Study:
- To review the genetic aspects of arterial thrombosis.
- To identify key thrombotic factors associated with increased risk for CAD.
- To explore the utility of genetic markers in managing vascular disease.
Main Methods:
- Review of genetic epidemiology studies.
- Analysis of in vitro laboratory data.
- Examination of genetic components of coagulation, fibrinolysis, and platelet receptors.
Main Results:
- Specific genetic variations in coagulation, fibrinolysis, and platelet receptors are linked to increased risk of acute coronary syndromes.
- Genetic factors contribute significantly to the development of arterial thrombosis in CAD.
- Inherited thrombotic markers offer potential for risk stratification.
Conclusions:
- Genetic assessment of thrombotic factors can enhance traditional risk factor evaluation for CAD.
- Personalized management strategies, including diagnostic testing and pharmacologic interventions, can be developed using genetic markers.
- Future clinical practice may integrate genetic insights for more effective vascular disease management.
Abstract:
Coronary artery disease is a leading cause of death worldwide and the largest killer of men and women in the United States. The pathophysiology of myocardial infarction is multifactorial, and numerous physiologic systems converge to dictate the formation of the two fundamental lesions, thrombosis and atherosclerosis. In this review we address genetic aspects of arterial thrombosis and the key thrombotic factors that have been associated with the increased risk for its development. Specifically, we consider components of coagulation, fibrinolysis, and platelet adhesive receptors, and we review the genetic epidemiology and in vitro laboratory data regarding their risk for the acute coronary syndromes. In combination with traditional risk factor assessment, in the near future these inherited markers can be used to manage patients with vascular disease through a better utilization of invasive or expensive diagnostic testing, as well as pharmacologic intervention.